Literature DB >> 15907006

Gastrointestinal stromal tumours in a single institute: is there an association to other gastrointestinal malignancies?

Katalin Kalmár1, Tamás Tornóczky, László Pótó, László Illényi, Károly Kalmár Nagy, Miklós Kassai, Dezso Kelemen, Ors Péter Horváth.   

Abstract

Our knowledge of Gastrointestinal Stromal Tumours (GIST) has been broadened in the last few years by the discovery of the key function of c-kit tyrosine kinase mutation in their pathogenesis. A single institution database is presented and a hypothesis is examined regarding probable connection between GIST and other gastrointestinal malignancies. Between 2000 and 2004 20 patients were admitted to our department with GIS tumour. With the addition of three cases detected between 1991 and 2000, and proved to be GIST retrospectively, 23 cases are followed. Mean age was 64.52 years, male to female ratio 11:12. Ten tumours originated from the stomach, ten from small bowel, one from rectum and two from mesenterium. All patients underwent surgery, 16 operations were completed with R0 radicality, one R1 and four R2 resections were performed. Follow-up ranged from 1 to 157 months. Five out of 23 patients died (21.7%), six patients live with metastatic disease, twelve are disease free. Amongst patient-, tumour- and treatment-related factors the prognostic significance of Fletcher's risk and radicality of resection was demonstrated (p<0.05). Significantly more synchronous or metachronous gastrointestinal malignancies were found is this population of GIST patients, when compared to the prevalence of malignancies in normal Hungarian population (p<0.001).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15907006

Source DB:  PubMed          Journal:  Magy Seb        ISSN: 0025-0295


  7 in total

1.  Coexistence of multiple liver metastases from sigmoid colon cancer and a gastrointestinal stromal tumor in the small intestine.

Authors:  Shinya Kato; Masaaki Miyo; Takeshi Kato; Masakazu Miyake; Yusuke Takahashi; Michihiko Miyazaki; Reishi Toshiyama; Takuya Hamakawa; Naoki Hama; Kazuhiro Nishikawa; Atsushi Miyamoto; Kiyoshi Mori; Masayuki Mano; Motohiro Hirao
Journal:  Clin J Gastroenterol       Date:  2022-01-06

2.  Development of multiple myeloma in a patient with gastrointestinal stromal tumor treated with imatinib mesylate: a case report.

Authors:  D Tzilves; A Gatopoulou; K Zervas; E Katodritou; F Patakiouta; A Tarpagos; I Katsos
Journal:  World J Gastroenterol       Date:  2007-04-07       Impact factor: 5.742

3.  Coexistence of gastrointestinal stromal tumors with other neoplasms.

Authors:  Łukasz Liszka; Ewa Zielińska-Pajak; Jacek Pajak; Dariusz Gołka; Joanna Huszno
Journal:  J Gastroenterol       Date:  2007-08-24       Impact factor: 7.527

4.  Frequence, spectrum and prognostic impact of additional malignancies in patients with gastrointestinal stromal tumors.

Authors:  K Kramer; S Wolf; B Mayer; S A Schmidt; A Agaimy; D Henne-Bruns; U Knippschild; M Schwab; M Schmieder
Journal:  Neoplasia       Date:  2015-01       Impact factor: 5.715

5.  Co-occurrence of liver metastasis of gastrointestinal stromal tumor and hepatocellular carcinoma: a case report.

Authors:  Kohei Yamashita; Yoshifumi Baba; Junji Kurashige; Masaaki Iwatsuki; Katsunori Imai; Daisuke Hashimoto; Yasuo Sakamoto; Akira Chikamoto; Naoya Yoshida; Toru Beppu; Hideo Baba
Journal:  Surg Case Rep       Date:  2016-09-01

6.  Cross-testing of major molecular markers indicates distinct pathways of tumorigenesis in gastric adenocarcinomas and synchronous gastrointestinal stromal tumors.

Authors:  Éva Kocsmár; Ildikó Kocsmár; Luca Szalai; Gábor Lendvai; Attila Szijártó; Zsuzsa Schaff; András Kiss; Ilona Kovalszky; Gergő Papp; Gábor Lotz
Journal:  Sci Rep       Date:  2020-12-17       Impact factor: 4.379

7.  The synchronous occurrence of squamous cell carcinoma and gastrointestinal stromal tumor (GIST) at esophageal site.

Authors:  Gian Paolo Spinelli; Evelina Miele; Federica Tomao; Luigi Rossi; Giulia Pasciuti; Angelo Zullo; Federica Zoratto; Jose Nunnari; Giovanni Codacci Pisanelli; Silverio Tomao
Journal:  World J Surg Oncol       Date:  2008-11-05       Impact factor: 2.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.